Mycoplasma pneumonia future or investigational therapies

Jump to: navigation, search

Pneumonia Main Page

Mycoplasma pneumonia Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Mycoplasma pneumonia from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

Treatment

Medical Therapy

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Mycoplasma pneumonia future or investigational therapies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Mycoplasma pneumonia future or investigational therapies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Mycoplasma pneumonia future or investigational therapies

CDC on Mycoplasma pneumonia future or investigational therapies

Mycoplasma pneumonia future or investigational therapies in the news

Blogs on Mycoplasma pneumonia future or investigational therapies

Directions to Hospitals Treating Mycoplasma pneumonia

Risk calculators and risk factors for Mycoplasma pneumonia future or investigational therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

Future or Investigational Therapies

Basic diagnostic strategy in clinical practice includes serology and standard polymerase chain reaction (PCR). New diagnostic techniques (PCR-related methods) may enable more rapid diagnosis. Exploration of the role of M. pneumoniae in community-acquired pneumonia and as a potential cofactor in severe pneumonia.

Sources

http://www.cdc.gov/ncidod/dbmd/diseaseinfo/mycoplasmapneum_t.htm

References



Linked-in.jpg